Sichenzia Ross Friedman Ference LLP Attorneys To Join Client DelMar Pharmaceuticals, Inc. at Nasdaq Opening Bell Ringing
Press Release – New York, NY – July 14, 2016 – Sichenzia Ross Friedman Ference LLP partners Gregory Sichenzia and David Manno and counsel Jeffrey Cahlon will join representatives of client DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a clinical stage drug development company with a focus on the treatment of cancer, at the Nasdaq MarketSite in Times Square to ring the July 14 opening bell.
Messrs. Sichenzia, Manno and Cahlon will take the stage along with a group of DelMar Pharmaceuticals leaders, including Chief Executive Officer Jeffrey Bacha. Join us and watch live on CNBC: 9:30am EST – Visit here to learn more about the NASDAQ Opening Bell
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP Attorneys Marc Ross and Mendy Piekarski Achieve Complete Dismissal of Shareholder Derivative Lawsuit - May 24, 2017
- Sichenzia Ross Ference Kesner Associate Cass Sanford Quoted in Business Insider Article on Topics Surrounding Reg A+ - May 12, 2017
- Sichenzia Ross Ference Kesner LLP Celebrates its 19th Anniversary - May 9, 2017